Breast Cancer During Pregnancy: Diagnosis, Treatment, Safety and Options in India

Being diagnosed with breast cancer is difficult at any time. Being diagnosed while pregnant can make the situation even more complicated. A pregnant woman may naturally notice changes in her breasts during pregnancy. The breasts become larger, more tender and denser, and these normal changes can sometimes make a new lump or other abnormality harder to recognize. (cancer.gov) The good news is that breast cancer can be treated during pregnancy. The treatment plan simply has to account for two patients: the mother and the developing baby. Surgery can generally be performed during pregnancy when needed. Certain chemotherapy treatments can be given after the first trimester, while treatments such as radiation therapy, hormone therapy and most HER2-targeted treatments are generally postponed until after delivery. (cancer.gov) This means that a breast cancer diagnosis during pregnancy does not automatically mean that treatment must wait until the baby is born. Instead, the oncology and obstetric teams work together to decide what needs to happen immediately, what can safely be given during pregnancy and what should wait. This guide supports the Breast Cancer Treatment in India pathway.

It is uncommon.

NCI estimates that breast cancer occurs in approximately 1 in 3,000 pregnancies. (cancer.gov)

The exact terminology can vary between studies and clinical settings, so doctors may distinguish between cancer diagnosed during pregnancy and cancer diagnosed after delivery while breastfeeding.

Pregnancy changes the breasts significantly.

These changes can make a new abnormality harder to distinguish from normal pregnancy-related changes. (cancer.gov)

That does not mean that a new breast lump during pregnancy should simply be attributed to pregnancy.

It should be assessed.

Do not wait until after delivery to have it checked.

Most breast lumps during pregnancy are not cancer.

However, the only way to determine the cause is through appropriate clinical assessment.

Your doctor may start with a breast examination and ultrasound.

If the finding remains suspicious, further imaging and biopsy may be recommended.

Pregnancy should not prevent appropriate investigation of a concerning breast change.

Yes.

Ultrasound does not use ionizing radiation and is commonly used as the initial imaging test when a breast abnormality is found during pregnancy. (cancer.gov)

The doctor may recommend additional imaging depending on what the ultrasound shows.

Yes, when medically necessary.

Mammography uses a relatively small amount of radiation, and appropriate precautions can be taken to minimize fetal exposure. (cancer.gov)

Pregnancy is therefore not an absolute reason to avoid mammography when a suspicious breast finding needs to be investigated.

The decision should be made by the treating team based on the clinical situation.

A breast biopsy can be performed during pregnancy when required.

A biopsy is important because imaging alone cannot establish whether a suspicious area is cancer.

These results help determine the treatment plan.

NCI specifically lists biopsy and hormone-receptor testing among the diagnostic procedures used for breast cancer during pregnancy. (cancer.gov)

MRI may sometimes be used when additional information is needed.

However, the decision about MRI during pregnancy is more complicated than simply ordering it as routine breast imaging.

In particular, the use of contrast agents requires careful consideration.

NCI notes that MRI without contrast may be used in selected circumstances during pregnancy, while gadolinium crosses the placenta and is generally avoided unless there is a strong clinical reason. (cancer.gov)

Your radiologist and oncology team should determine whether MRI is appropriate.

The pregnancy itself does not change the biological characteristics of the tumor.

But it changes which treatments can safely be given and when.

This question is more complicated than it first appears.

Pregnancy can make breast cancer harder to detect, which may contribute to diagnosis at a later stage.

Research comparing outcomes of pregnant and non-pregnant patients has produced mixed results. Some studies find similar outcomes when cancers are compared at the same stage, while other research has reported differences. (cancer.gov)

rather than assuming pregnancy itself determines the outcome.

Yes.

Surgery is an important part of treatment for many pregnant patients with early breast cancer.

The choice depends on the cancer and the stage of pregnancy. (cancer.gov)

The surgical plan also has to account for anesthesia and obstetric monitoring.

Modern anesthesia can be used during pregnancy when surgery is medically necessary.

However, pregnancy changes how the body responds to anesthesia and surgery.

The timing of surgery and the medications used are selected with both the mother's and baby's safety in mind. (cancer.org)

Both procedures may be considered.

However, the timing of pregnancy can influence the decision.

Radiation therapy is generally postponed until after delivery.

Because radiation is commonly part of treatment after lumpectomy, some patients diagnosed earlier in pregnancy may instead be advised to undergo mastectomy to avoid delaying necessary radiation for too long. (cancer.gov)

This does not mean that mastectomy is automatically required during pregnancy.

The decision depends on the cancer, timing, available treatment options and the patient's circumstances.

Lymph-node evaluation may be needed because breast cancer can spread to lymph nodes.

The approach during pregnancy requires additional consideration.

NCI notes that evidence regarding sentinel lymph-node biopsy during pregnancy is limited, while the American Cancer Society describes circumstances in which sentinel-node biopsy may be considered with specific techniques. (cancer.gov; cancer.org)

The blue dye sometimes used in sentinel-node mapping is generally avoided during pregnancy.

The exact lymph-node procedure should therefore be decided by the breast surgical team in consultation with the obstetric team.

Yes, but timing is critical.

Chemotherapy is generally not given during the first trimester because this is a major period of fetal development. (cancer.org)

Certain chemotherapy regimens can be used during the second and third trimesters.

NCI notes that early-stage breast cancer during pregnancy may be treated with chemotherapy after the first trimester when indicated. (cancer.gov)

The specific drugs and schedule must be selected by the oncology team.

During the first trimester, the developing fetus undergoes major organ formation.

Exposure to certain chemotherapy medicines during this period can increase the risk of developmental problems and pregnancy loss.

For that reason, if chemotherapy is necessary, doctors generally plan it after the first trimester when possible. (cancer.org)

This is one of the situations where treatment timing becomes especially important.

This can be one of the most difficult situations.

Surgery may still be possible.

Chemotherapy may need to be delayed until the second trimester.

Treatments that are not considered safe during pregnancy may need to wait until after delivery.

For aggressive or advanced cancers where immediate treatment is critical, the medical team will discuss all available options with the patient.

Breast radiation is generally postponed until after delivery.

Radiation involves ionizing radiation, and therapeutic doses can expose the developing fetus to potentially harmful radiation. (cancer.gov)

This can create an important treatment-planning issue.

For example, a patient who normally would have lumpectomy followed by radiation may need a different surgical approach depending on how far along the pregnancy is.

If radiation was postponed during pregnancy, it can generally be incorporated into treatment after delivery when it remains indicated.

The oncology team will establish the sequence.

Generally, no.

If the breast cancer is ER-positive or PR-positive, hormone therapy may be an important part of treatment.

But hormone therapy is generally delayed until after delivery because these medicines can affect the fetus. (cancer.gov)

For example, tamoxifen is not considered appropriate during pregnancy.

The treatment can be started after delivery when the medical team determines that it is appropriate.

HER2-targeted medicines are generally not used during pregnancy.

Trastuzumab, for example, has been associated with fetal complications, particularly involving the developing kidneys and amniotic fluid. (cancer.org)

Other HER2-directed medicines are also generally avoided.

This means that a patient with HER2-positive breast cancer may receive some components of treatment during pregnancy while postponing HER2-directed therapy until after delivery.

The exact sequence depends on the cancer and gestational age.

Immunotherapy is generally avoided during pregnancy.

There is limited evidence about the safety of immune checkpoint inhibitors during pregnancy, and there are concerns about the effect of altering the maternal immune system on pregnancy. (cancer.org)

If immunotherapy would ordinarily form part of treatment, the oncology team has to determine whether it can safely be postponed or whether the clinical situation requires a different approach.

Most targeted breast cancer treatments are not routinely given during pregnancy.

This includes many HER2-targeted medicines and other targeted therapies.

The reason is that these medicines can affect fetal development, and safety data during pregnancy are limited. (cancer.org)

Targeted therapy can often be introduced after delivery when medically appropriate.

Usually not.

Many chemotherapy, hormone and targeted medicines can pass into breast milk and potentially harm the baby.

Therefore, breastfeeding is generally not recommended while receiving these systemic cancer treatments. (cancer.org)

If cancer is diagnosed after delivery while the mother is breastfeeding, the treatment team will explain when breastfeeding needs to stop.

The situation is slightly different from breast cancer diagnosed during pregnancy.

The baby is no longer exposed through the placenta, but some cancer medicines can enter breast milk.

Diagnostic imaging and biopsy can still be performed when necessary.

The treatment plan will determine whether breastfeeding can continue.

If chemotherapy, hormone therapy or targeted treatment is required, breastfeeding will generally need to stop. (cancer.gov)

No.

Breast cancer does not normally pass from a pregnant mother to her fetus.

The main medical concern is the effect that cancer treatment may have on fetal development. (cancer.gov)

This distinction is important because patients sometimes worry that the cancer itself will spread directly to the baby.

That is not how breast cancer normally behaves.

Not routinely.

A breast cancer diagnosis does not automatically require termination of pregnancy.

Many patients can receive surgery and, when appropriate, chemotherapy during pregnancy while postponing treatments that are unsafe for the fetus. (cancer.org)

However, there can be exceptional circumstances.

For example, a patient with a very aggressive or advanced cancer diagnosed very early in pregnancy may face a situation where the safest cancer treatment cannot be given while continuing the pregnancy.

In such cases, the decision requires detailed discussion between the patient and her medical team.

It is not a decision that can be made from the diagnosis alone.

Available evidence does not support ending a pregnancy as a routine strategy to improve breast cancer outcomes.

NCI and the American Cancer Society both note that pregnancy termination does not generally improve prognosis. (cancer.gov; cancer.org)

There can, however, be exceptional cases where treatment needs create a serious conflict between maternal cancer care and continuation of pregnancy.

Those situations require individualized medical and ethical discussion.

The goal of treatment remains the same: control or eliminate the cancer while protecting the pregnancy as much as medically possible.

Some treatments may need to be delayed.

Others can be given during pregnancy.

Therefore, the treatment plan may look different from that of a non-pregnant patient with the same diagnosis.

The stage and biological characteristics of the cancer remain central to deciding treatment.

Breast cancer during pregnancy requires more coordination than ordinary breast cancer care.

The oncologist and obstetric team need to communicate throughout treatment.

The pregnancy needs its own monitoring while cancer treatment is taking place.

This does not replace the oncology team.

Both teams are necessary.

Oncology teams in Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad can confirm the next step. Hospitals in Delhi NCR and Mumbai handle international follow-up.

Sometimes.

Chemotherapy is generally avoided close to delivery because it can affect blood counts and increase complications around childbirth. (cancer.org)

The obstetric and oncology teams coordinate the timing.

It can.

Chemotherapy and some hormone-related treatments can affect ovarian function and future fertility.

Because pregnancy itself is already ongoing, fertility preservation before treatment is obviously different from the situation faced by someone who has not yet conceived.

For patients who want more children after completing treatment, fertility and reproductive planning should still be discussed early.

The important point is that this conversation should happen before treatment begins whenever possible.

India has cancer centers capable of treating breast cancer in pregnant patients, but this is a situation where choosing a hospital based only on the availability of a breast surgeon is not enough.

The hospital should be able to coordinate oncology and obstetric care.

This multidisciplinary setup is important because treatment decisions can change as the pregnancy progresses.

If you have been diagnosed with breast cancer during pregnancy and are considering treatment in India, send your medical records before traveling whenever possible.

The Indian oncology team can then review the case before you travel.

This can be particularly helpful when the treatment sequence needs to be planned around a specific gestational age.

Yes.

A patient may receive cancer treatment in India while continuing certain aspects of pregnancy care with an obstetrician in her home country.

However, communication between the teams is essential.

There is no fixed cost.

The pregnancy adds another layer of medical care, so expenses can include both cancer treatment and obstetric monitoring.

The final cost depends heavily on the cancer stage, subtype, trimester and treatment sequence.

For this reason, an individual treatment quotation should be prepared after the medical records have been reviewed.

GAF Healthcare's Breast Cancer Treatment in India page can serve as the main treatment resource, while relevant surgery and systemic-treatment cost pages can be linked once the patient's treatment plan is established.

A breast cancer diagnosis during pregnancy creates many decisions at once.

Having these answers in writing can make an extremely stressful situation easier to manage.

Frequently Asked Questions Can a woman have breast cancer while pregnant?

Yes. Breast cancer is uncommon during pregnancy but can occur. NCI estimates approximately one case per 3,000 pregnancies. (cancer.gov)

Yes. Surgery is generally possible, and certain chemotherapy can be given after the first trimester. Some other treatments are postponed until after delivery. (cancer.gov)

Yes. Ultrasound does not use ionizing radiation and is commonly used to investigate a breast lump during pregnancy. (cancer.gov)

Yes, when medically necessary. Mammography uses a small amount of radiation, and precautions can be taken to minimize fetal exposure. (cancer.gov)

Yes. Biopsy is an important part of diagnosing suspicious breast changes during pregnancy. (cancer.gov)

Certain chemotherapy can be given during the second and third trimesters. It is generally avoided during the first trimester. (cancer.org)

Breast radiation is generally delayed until after delivery because therapeutic radiation can harm the developing fetus. (cancer.gov)

Usually not. Hormone therapy is generally postponed until after delivery. (cancer.gov)

Some components of treatment can be given, but HER2-targeted therapies such as trastuzumab are generally avoided during pregnancy and may be started after delivery when appropriate. (cancer.org)

Breast cancer itself does not normally pass from the mother to the fetus. Treatment safety is the major concern during pregnancy. (cancer.gov)

No. Pregnancy termination is not routinely required. Treatment can often be adapted to the stage of pregnancy. Exceptional situations involving aggressive or advanced disease require individualized discussion. (cancer.org)

Some treatments can affect fetal development, which is why treatment selection and timing are carefully planned. Surgery and certain chemotherapy can be used during pregnancy, while radiation, hormone therapy and many targeted treatments are generally delayed. (cancer.gov)

Breastfeeding is generally not recommended during chemotherapy because medicines can pass into breast milk and potentially harm the baby. (cancer.org)

Yes. Treatment should be coordinated between a multidisciplinary breast cancer team and a high-risk obstetric or maternal-fetal medicine team.

Yes. Breast cancer can usually be treated during pregnancy, although the type and timing of treatment may need to be modified to protect the developing baby. (cancer.gov)

Clinical examination, ultrasound, mammography and biopsy can be used when breast cancer is suspected. Ultrasound does not use radiation, and mammography can be performed when clinically necessary with appropriate precautions. (cancer.gov)

Yes. Surgery is generally considered possible during pregnancy, with the timing and anesthesia plan coordinated between the surgical and obstetric teams. (cancer.org)

Certain chemotherapy medicines can be given during the second and third trimesters. Chemotherapy is generally avoided during the first trimester and is usually stopped several weeks before delivery. (cancer.org)

Radiation to the breast is generally postponed until after delivery because radiation can harm the developing fetus. (cancer.gov)

Hormone therapy is generally delayed until after delivery because these medicines can affect the fetus. (cancer.org)

HER2-targeted medicines such as trastuzumab are generally avoided during pregnancy because of potential fetal harm. (cancer.gov)

Breast cancer itself does not normally pass from the mother to the fetus. The main concern is choosing cancer treatment that controls the mother's cancer while minimizing risks to the developing baby. (cancer.gov)

Not routinely. The decision is highly individual and depends on the cancer, stage, pregnancy stage and treatment options. Most patients can be treated without automatically ending the pregnancy. (cancer.org)

Yes. Treatment requires coordination between a breast cancer team and a high-risk obstetric team, with treatment timing planned around the pregnancy.

Breast cancer diagnosed during pregnancy, within one year after giving birth or during lactation is often referred to as pregnancy-associated breast cancer. (cancer.gov)

• Breast Cancer Treatment in India
• Hormone therapy side effects
• Chemotherapy side effects
• Targeted therapy side effects
• Radiation therapy
• Diagnosis
• International patients
• Chemotherapy doctors · Hormone therapy doctors
• Radiation oncology doctors
• Breast-conserving surgery doctors